Natural Biogenex Profile
Key Indicators
- Authorised Capital ₹ 72.25 Cr
- Paid Up Capital ₹ 68.89 Cr
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 79.50 Cr
- Revenue Growth 99.88%
- Profit Growth 43.25%
- Ebitda -44.95%
- Net Worth 69318.03%
- Total Assets 193.23%
About Natural Biogenex
Natural Biogenex Private Limited (NBPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 August 2020 (Four years and six months 1 days old ). Its registered office is in Bangalore, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 72.25 Cr and a paid-up capital of Rs 68.89 Cr.
The company currently has active open charges totaling ₹79.50 Cr.
The Key Managerial Personnel (KMP) at Natural Biogenex Private Limited India are Raj Prasad as CFO and Shilpa Burman as Company Secretary. Laxminarayan Moondra, Sunil Laxminarayana, Rangachar Coletore, and Two other members serve as directors at the Company.
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239KA2020PTC137602
- Company No.
137602
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2020
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Natural Biogenex?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Laxminarayana  | Managing Director | 23-Aug-2020 | Current |
| Raj Prasad | CFO | 19-Nov-2022 | Current |
| Shilpa Burman | Company Secretary | 28-Oct-2022 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramesh Kannan | Director | 17-Jun-2023 | Current |
| Pramod Kasat | Director | 08-Feb-2022 | Current |
| Laxminarayan Moondra | Director | 24-Mar-2023 | Current |
| Rangachar Coletore | Director | 08-Feb-2022 | Current |
Financial Performance of Natural Biogenex.
Natural Biogenex Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 99.88% increase. The company also saw a substantial improvement in profitability, with a 43.25% increase in profit. The company's net worth Soared by an impressive increase of 69318.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Natural Biogenex?
In 2023, Natural Biogenex had a promoter holding of 89.99% and a public holding of 10.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sai India LimitedRangachar Coletore is a mutual person
Safepack Industries LimitedPramod Kasat is a mutual person
Polyene General Industries Private LimitedRangachar Coletore is a mutual person
Indian Machine Tool Manufacturers AssociationRangachar Coletore is a mutual person
Apex Hospitals Private LimitedRamesh Kannan is a mutual person
Jc Biotech Private LimitedPramod Kasat is a mutual person
Charges (Loans)
₹79.50 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 35.00 Cr
- Hdfc Bank Limited : 32.00 Cr
- Others : 12.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jul 2024 | Others | ₹12.50 Cr | Open |
| 25 Feb 2022 | State Bank Of India | ₹35.00 Cr | Open |
| 17 Oct 2021 | Hdfc Bank Limited | ₹32.00 Cr | Open |
How Many Employees Work at Natural Biogenex?
Natural Biogenex has a workforce of 43 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Natural Biogenex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natural Biogenex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
